Acoramidis Shows Encouraging Results in ATTR Cardiomyopathy Acoramidis Shows Encouraging Results in ATTR Cardiomyopathy

Lead author of the ATTRibute-CM trial says it was"robustly positive," and shows"the tantalizing possibility of genuine clinical improvements" for this progressive and fatal condition.Medscape Medical News
Source: Medscape Neurology and Neurosurgery Headlines - Category: Neurology Tags: Cardiology News Source Type: news